Kodiak Sciences
Présence
Kodiak Sciences fait partie des...
Kodiak Sciences est une société cotée sous le symbole boursier KOD (US).
Dirigeants
Voir l'organigramme avec ses 20 principaux dirigeants
Biographies les plus recherchées chez Kodiak Sciences
- Victor Perlroth, Chairman and Chief Executive Officer
- Taiyin Yang, Director
- Charles Bancroft, Director
Créer une alerte
pour suivre les mouvements de dirigeants chez Kodiak Sciences.
Biotechnologie
Kodiak Sciences a 2 292 concurrents dont Eurofins (Luxembourg), Lonza (Suisse) et Adaptive Phage Therapeutics (Etats—Unis).
Actualités en fusion/acquisition en Biotechnologie.
- Lycia Therapeutics vient d'annoncer une levée de fonds de 107 millions de dollars. (publié le 15 mai 2024).
- Attovia Therapeutics vient d'annoncer une levée de fonds de 150 millions de dollars. (publié le 14 mai 2024).
- Bruker has announced the acquisition of NanoString Technologies (publié le 13 mai 2024).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Kodiak Sciences
- Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 - Two Studies in Diabetic Macular Edema and One Study in Macular Edema Due to Retinal Vein Occlusion | Kodiak Sciences Inc.
- Kodiak Sciences to Present at Upcoming Conferences | Kodiak Sciences Inc.
- Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent Business Highlights | Kodiak Sciences Inc.
- Lonza's Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301 - an Antibody Biopolymer Conjugate for Retinal Diseases | Kodiak Sciences Inc.
- Kodiak Sciences to Host R&D Webcast to Review Recent Data from the Ongoing Phase 1b Study of KSI-301 and Highlight KSI-301 Clinical Development Progress | Kodiak Sciences Inc.
- Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Society of Retin
- Kodiak Sciences Announces Upcoming Presentation of KSI-301 Clinical Study Data at American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting and R&D Webinar | Kodiak Sciences Inc.
- Kodiak Sciences to Present at Upcoming Conferences | Kodiak Sciences Inc.
- Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference | Kodiak Sciences Inc.
- Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights | Kodiak Sciences Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Kodiak Sciences
- Kodiak Sciences sur Wikipédia, Google News & Yahoo Finance en 1-click
- Kodiak Sciences sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Victor Perlroth 
Appelez Kodiak Sciences au +1 650...
